Investor Presentation slide image

Investor Presentation

adj. ebitda reconciliation AR Loss from continuing operations (GAAP) Incremental costs to acquire cannabis inventory in business combination Interest (within COGS) Depreciation and amortization Acquisition and Transaction Costs Stock-based compensation, non-cash all amounts in USD, in thousands Start-up costs¹ (Gain) loss on sale of assets Other² three months ended September 30 2023 2022 (1,451) (19,462) 776 22,019 (1,182) 3,410 2,909 22 1,924 29,878 CSE:AYR.A | OTC:AYRWF 28,427 486 1,694 19,549 965 Adjusted EBITDA from continuing operations (non-GAAP) 1) Includes costs to prepare a location for its intended use, including facilities not yet operating at scale. Start-up costs are expensed as incurred and are not indicative of ongoing operations. 2) Other non-core costs including non-operating adjustments, severance costs and non-cash inventory write-downs 9,359 2,930 1,810 1,337 38,130 18,668 17
View entire presentation